Rinda Sama Net Worth

The estimated Net Worth of Rinda Sama is at least $23.4 Millón dollars as of 31 January 2024. Mr. Sama owns over 28,000 units of Axonics Inc stock worth over $5,763,285 and over the last 6 years he sold AXNX stock worth over $15,311,840. In addition, he makes $2,330,210 as Chief Operating Officer at Axonics Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Sama AXNX stock SEC Form 4 insiders trading

Rinda has made over 30 trades of the Axonics Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 28,000 units of AXNX stock worth $1,924,440 on 31 January 2024.

The largest trade he's ever made was selling 75,000 units of Axonics Inc stock on 15 April 2021 worth over $4,431,000. On average, Rinda trades about 14,688 units every 52 days since 2019. As of 31 January 2024 he still owns at least 83,854 units of Axonics Inc stock.

You can see the complete history of Mr. Sama stock trades at the bottom of the page.

Rinda Sama biography

Rinda K. Sama serves as Chief Operating Officer of the Company. From May 2014 to August 2018, Mr. Sama served as our Vice President, Operations and Quality. From June 2011 to May 2014, Mr. Sama served as Director, Operations and Quality of Vessix Vascular, Inc. Mr. Sama holds a B.S. in Biomedical Engineering from Karnatak University Dharwad, a M.S. in Biomedical Engineering from the University of Southern California and a M.B.A from the University of California, Irvine.

What is the salary of Rinda Sama?

As the Chief Operating Officer of Axonics Inc, the total compensation of Rinda Sama at Axonics Inc is $2,330,210. There are 2 executives at Axonics Inc getting paid more, with Raymond Cohen having the highest compensation of $6,147,640.

How old is Rinda Sama?

Rinda Sama is 41, he's been the Chief Operating Officer of Axonics Inc since 2018. There are 20 older and 2 younger executives at Axonics Inc. The oldest executive at Axonics Inc is Nancy Snyderman, 68, who is the Independent Director.

What's Rinda Sama's mailing address?

Rinda's mailing address filed with the SEC is 26, Technology Drive, Irvine Spectrum, Irvine, Orange County, California, 92618, United States.

Insiders trading at Axonics Inc

Over the last 6 years, insiders at Axonics Inc have traded over $108,010,643 worth of Axonics Inc stock and bought 4,672,163 units worth $70,180,620 . The most active insiders traders include Asset Management, Lp Chen B..., Shahzad Malik y Geoff Pardo. On average, Axonics Inc executives and independent directors trade stock every 15 days with the average trade being worth of $4,280,711. The most recent stock trade was executed by Raymond W Cohen on 24 July 2024, trading 103,896 units of AXNX stock currently worth $2,383,374.

What does Axonics Inc do?

axonics modulation technologies, inc is a privately-held medical device company developing an innovative neuromodulation platform based on a miniaturized rechargeable fully-implantable ipg licensed from the alfred mann foundation. the axonics sacral neuromodulation system is designed to improve the experience of both clinicians and patients suffering from urinary and fecal dysfunction.

Complete history of Mr. Sama stock trades at Axonics Inc

Axonics Inc executives and stock owners

Axonics Inc executives and other stock owners filed with the SEC include:

• Raymond Cohen,
  Chief Executive Officer, Director
• Dan Dearen,
  President, Chief Financial Officer
• Rinda Sama,
  Chief Operating Officer
• Raymond W. Cohen,
  CEO & Director
• Danny L. Dearen,
  Pres & CFO
• Dr. Karen L. Noblett M.D., M.A.S.,
  Chief Medical Officer
• Rinda K. Sama,
  Chief Operating Officer
• Robert McNamara,
  Independent Director
• Juliet Tammenoms Bakker,
  Independent Director
• Alfred J. Ford Jr.,
  Chief Commercial Officer
• Erik Amble,
  Independent Director
• Michael Carrel,
  Independent Chairman of the Board
• Jane Kiernan,
  Independent Director
• Nancy Snyderman,
  Independent Director
• Karen Noblett,
  Chief Medical Officer
• Prabodh Mathur,
  Chief Product Development Officer
• Alfred Ford,
  Chief Commercial Officer
• John Woock,
  Chief Marketing Officer
• Dr. Karen L. Noblett M.A.S., M.D.,
  Chief Medical Officer
• Michael V. Williamson Esq., J.D.,
  Sr. VP, Gen. & IP Counsel
• Michael V. Williamson,
  Sr. VP, Gen. & IP Counsel
• Dr. John Woock Ph.D.,
  Exec. VP, Chief Marketing & Strategy Officer
• Aaron Pettit,
  Gen. Counsel & Chief Compliance Officer
• Neil Bhalodkar,
  VP of Investor Relations
• Guangqiang Jiang Ph.D.,
  Chief Technology Officer
• Esteban Lopez,
  
• John George Petrovich,
  Director
• Shahzad Malik,
  Director
• Life Sciences Llp Advent Li...,
  
• Partners Bio Discovery 4 Fc...,
  
• E. Mann Foundation For Scie...,
  
• Capital Partners Iii, Llcen...,
  
• Innovation V Ltd Neo Med In...,
  
• Healthcare Holding B.V.Gild...,
  
• Asset Management, Lp Chen B...,
  
• Michael V. Williamson,
  SVP, General Counsel
• Guangqiang Jiang,
  Chief Technology Officer
• Zhong Zac & Cloud Holdings ...,
  
• Raphael Wisniewski,
  
• Robert E Mcnamara,
  
• Geoff Pardo,
  
• David M Demski,
  
• Kari Leigh Keese,
  Chief Financial Officer